CERo Therapeutics News

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jun 5 17:18 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 16 06:31 ET

S-1: General form for registration of securities under the Securities Act of 1933

May 6 17:15 ET

8-K: Current report

May 3 16:32 ET

8-K: Current report

May 1 16:20 ET

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 26 16:39 ET

CERo Therapeutics | DEF 14A: Definitive information statements

Apr 15 16:40 ET

CERo Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Apr 10 16:09 ET

CERo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 3 17:31 ET

CERo Therapeutics | 8-K/A: Current report (Amendment)

Apr 2 07:14 ET

CERo Therapeutics | NT 10-K: Others

Apr 2 06:09 ET

CERo Therapeutics | 8-K: Current report

Feb 28 09:02 ET

CERo Therapeutics | 8-K/A: Current report (Amendment)

Feb 27 08:31 ET

CERo Therapeutics | 8-K: Current report

Feb 15 12:18 ET

PHOENIX BIOTECH ACQUISITION CORP | 8-K: Current report

Feb 14 12:17 ET

PHOENIX BIOTECH ACQUISITION CORP | 8-K: Current report

Feb 12 16:16 ET

PHOENIX BIOTECH ACQUISITION CORP | 8-K: Current report

Feb 6 06:16 ET

PHOENIX BIOTECH ACQUISITION CORP | DEFM14A: Definitive proxy statement relating to merger or acquisition

Jan 22 00:00 ET

PHOENIX BIOTECH ACQUISITION CORP | 8-K: Current report

Jan 5 00:00 ET

PHOENIX BIOTECH ACQUISITION CORP | DEF 14A: Definitive information statements

Dec 14, 2023 16:37 ET